Yanto Lundardi-Iskandar

Title: Yanto Lundardi-Iskandar: Innovator in Therapeutic Polypeptides

Introduction

Yanto Lundardi-Iskandar is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic polypeptides. His work focuses on innovative solutions for various medical conditions, showcasing his commitment to advancing healthcare.

Latest Patents

Yanto holds a patent for "Biologically active polypeptides derived from a novel early stage pregnancy factor designated Maternin." This invention relates to therapeutic polypeptides isolated from beta-human chorionic gonadotropin (β-hCG) found in human early pregnancy urine. The polypeptides, now synthetically produced and designated Maternin, are useful in treating and preventing various medical conditions. Their therapeutic effects include anti-HIV, anti-cancer, anti-wasting, prohematopoietic, and anti-angiogenic effects. The invention also encompasses pharmaceutical compositions comprising these therapeutic polypeptides, along with methods for their application in medical treatments.

Career Highlights

Yanto is associated with Nobel Biosciences LLC, where he continues to innovate and develop new therapeutic solutions. His work has the potential to impact numerous patients suffering from various ailments, demonstrating his dedication to improving health outcomes.

Collaborations

Yanto has collaborated with esteemed professionals in the field, including Robert C. Gallo and Joseph Bryant. These partnerships highlight his commitment to advancing research and development in biotechnology.

Conclusion

Yanto Lundardi-Iskandar is a pioneering inventor whose work in therapeutic polypeptides is paving the way for new medical treatments. His contributions to the field are invaluable and reflect his dedication to enhancing healthcare solutions.